{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:20:38Z","timestamp":1787750438949,"version":"build-2784847793"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    High mortality in patients with sepsis, acute myocardial infarction (AMI), cardiac arrest (CA), and Takotsubo syndrome (TS) is the main problem of modern medicine. Polypeptide procalcitonin is synthesized and secreted by different cells and tissues. Septic shock (SS), cardiogenic shock (CS), CA, CoronavIrus disease 2019, and TS significantly increase circulating procalcitonin levels. Lipopolysaccharide stimulates the production of procalcitonin through the activation of toll-like receptor-4 and transcription factor nuclear factor of \u03ba light polypeptide gene enhancer in B-cells. Procalcitonin activates the calcitonin gene-related peptide receptor in endothelial cells and an unknown receptor. Procalcitonin causes lung microvessel injury, apoptosis, and pyroptosis of endothelial cells. Procalcitonin antibodies increase survival in animals with sepsis. Exogenous procalcitonin exacerbates sepsis in animals. Procalcitonin is involved in the pathogenesis of SS, CS, and death after CA, and stress-induced cardiac injury. An increase in circulating procalcitonin levels is associated with acute heart failure, but not microvascular injury or intramyocardial hemorrhage in patients with AMI. An increase in circulating procalcitonin levels is a predictor of mortality after SS, CS, and CA. The elevation in the procalcitonin level indicates a worsening of the course of pneumonia. Mixed CS is observed in patients with AMI and TS and is often associated with sepsis and systemic inflammatory response. Hence, calcitonin gene-related peptide receptor antagonists and procalcitonin monoclonal antibody may become the basis for the development of drugs for the treatment of SS, CS, TS, and prevention of death after CA.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000001368","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:01:02Z","timestamp":1782500462000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Role of Polypeptide Procalcitonin in Cardiac and Microvascular Injury in Sepsis, Myocardial Ischemia\/Reperfusion, Cardiac Arrest, Mixed Shock, and Stress"],"prefix":"10.1097","author":[{"given":"Leonid N.","family":"Maslov","sequence":"first","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Popov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Mukhomedzyanov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa S.","family":"Slidnevskaya","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav R.","family":"Latonov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Naryzhnaya","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr S.","family":"Gorbunov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Physiology, Hebei Medical University, Shijiazhuang, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A.","family":"Ilinykh","sequence":"additional","affiliation":[{"name":"Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX"},{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"R1-20260626","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI.","volume":"369","author":"Menees","year":"2013","journal-title":"N Engl J Med"},{"key":"R2-20260626","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/heartjnl-2017-311181","article-title":"Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.","volume":"103","author":"Fabris","year":"2017","journal-title":"Heart"},{"key":"R3-20260626","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/heartjnl-2017-312366","article-title":"Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.","volume":"104","author":"Olier","year":"2018","journal-title":"Heart"},{"key":"R4-20260626","first-page":"6","article-title":"Modern ways to reduced mortality of myocardial infarction. What should be done?","volume":"43","author":"Barbarash","year":"2023","journal-title":"Sib Sci Med J"},{"key":"R5-20260626","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/1573403X16666200129114330","article-title":"Takotsubo syndrome: clinical manifestations, etiology and pathogenesis.","volume":"17","author":"Prokudina","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"R6-20260626","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association.","volume":"136","author":"Van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R7-20260626","doi-asserted-by":"crossref","first-page":"45","DOI":"10.29001\/2073-8552-2021-36-4-45-51","article-title":"Cardiogenic shock: what\u2019s new?","volume":"36","author":"Panteleev","year":"2021","journal-title":"Siberian J Clin Exp Med"},{"key":"R8-20260626","first-page":"375","article-title":"Clinical features of Chinese patients with Takotsubo syndrome.","volume":"50","author":"Lu","year":"2022","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R9-20260626","doi-asserted-by":"crossref","first-page":"2416784","DOI":"10.1016\/j.pulmoe.2023.02.005","article-title":"Effects of hyperoxemia in patients with sepsis \u2013 a post-hoc analysis of a multicentre randomized clinical trial.","volume":"31","author":"Catalisano","year":"2025","journal-title":"Pulmonology"},{"key":"R10-20260626","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0000000000001078","article-title":"A review of inotropes and inopressors for effective utilization in patients with acute decompensated heart failure.","volume":"78","author":"Nandkeolyar","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"R11-20260626","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1111\/1440-1681.70063","article-title":"Novel semisynthetic derivative of dehydrozingerone (DHZ-15) modulates lipopolysaccharide-stimulated macrophages by targeting the NF-\u03baB\/p65 pathway and in vivo evaluation in a sepsis BALB\/c model.","volume":"52","author":"Qasam","year":"2025","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R12-20260626","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00392-007-0626-5","article-title":"Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.","volume":"97","author":"Debrunner","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"R13-20260626","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1476-5381.2009.00433.x","article-title":"Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.","volume":"159","author":"Becker","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R14-20260626","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1432-1033.1975.tb02176.x","article-title":"Calcitonin biosynthesis: evidence for a precursor.","volume":"55","author":"Moya","year":"1975","journal-title":"Eur J Biochem"},{"key":"R15-20260626","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0006-291X(80)91562-4","article-title":"Biosynthesis of human calcitonin: evidence for a prohormone.","volume":"95","author":"Jullienne","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-20260626","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(84)80839-X","article-title":"The complete sequence of human preprocalcitonin.","volume":"167","author":"Le Moullec","year":"1984","journal-title":"FEBS Lett"},{"key":"R17-20260626","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/S0021-9258(17)43228-5","article-title":"Identification of procalcitonin in a rat medullary thyroid carcinoma cell line.","volume":"259","author":"Birnbaum","year":"1984","journal-title":"J Biol Chem"},{"key":"R18-20260626","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/CCLM.1999.119","article-title":"Molecular aspects and natural source of procalcitonin.","volume":"37","author":"Russwurm","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"R19-20260626","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection.","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"key":"R20-20260626","first-page":"1605","article-title":"Procalcitonin increase after endotoxin injection in normal subjects.","volume":"79","author":"Dandona","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20260626","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-2143(99)90053-7","article-title":"Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro.","volume":"134","author":"Oberhoffer","year":"1999","journal-title":"J Lab Clin Med"},{"key":"R22-20260626","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00024382-200116020-00004","article-title":"Procalcitonin and CGRP-I mRNA expression in various human tissues.","volume":"16","author":"Russwurm","year":"2001","journal-title":"Shock"},{"key":"R23-20260626","first-page":"396","article-title":"Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis 1.","volume":"86","author":"M\u00fcller","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20260626","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-2478(02)00158-X","article-title":"Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes.","volume":"84","author":"Balog","year":"2002","journal-title":"Immunol Lett"},{"key":"R25-20260626","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1210\/en.2003-0854","article-title":"In vitro and in vivo calcitonin i gene expression in parenchymal cells: a novel product of human adipose tissue.","volume":"144","author":"Linscheid","year":"2003","journal-title":"Endocrinology"},{"key":"R26-20260626","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.CCM.0000134404.63292.71","article-title":"Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.","volume":"32","author":"Linscheid","year":"2004","journal-title":"Crit Care Med"},{"key":"R27-20260626","doi-asserted-by":"crossref","first-page":"248963","DOI":"10.1155\/2014\/248963","article-title":"The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro.","volume":"2014","author":"Rami","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R28-20260626","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.rvsc.2011.09.011","article-title":"Procalcitonin gene expression after LPS stimulation in the porcine animal model.","volume":"93","author":"Zannoni","year":"2012","journal-title":"Res Vet Sci"},{"key":"R29-20260626","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.micinf.2015.09.027","article-title":"MiR-125b regulates procalcitonin production in monocytes by targeting Stat3.","volume":"18","author":"Zhang","year":"2016","journal-title":"Microbes Infect"},{"key":"R30-20260626","doi-asserted-by":"crossref","first-page":"155317","DOI":"10.1016\/j.cyto.2020.155317","article-title":"LPS induced PCT production via TLR-4\/NF-\u043aB passway: it is the difference of G\u2212\/G+ bacteremia rats.","volume":"137","author":"Hui-Heng","year":"2021","journal-title":"Cytokine"},{"key":"R31-20260626","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1007\/s001340051146","article-title":"The natural elimination rate of procalcitonin in patients with normal and impaired renal function.","volume":"26","author":"Meisner","year":"2000","journal-title":"Intensive Care Med"},{"key":"R32-20260626","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00003643-200102000-00004","article-title":"The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function.","volume":"18","author":"Meisner","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"R33-20260626","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3565(24)36674-1","article-title":"Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability.","volume":"281","author":"Thomas","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R34-20260626","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/322031","article-title":"Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia.","volume":"184","author":"Preas","year":"2001","journal-title":"J Infect Dis"},{"key":"R35-20260626","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00024382-200014010-00013","article-title":"Procalcitonin and proinflammatory cytokine interactions in sepsis.","volume":"14","author":"Whang","year":"2000","journal-title":"Shock"},{"key":"R36-20260626","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/adc.2005.077446","article-title":"Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.","volume":"91","author":"Arkader","year":"2006","journal-title":"Arch Dis Child"},{"key":"R37-20260626","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/17482941.2010.498920","article-title":"Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data.","volume":"12","author":"Picariello","year":"2010","journal-title":"Acute Card Care"},{"key":"R38-20260626","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0218492320987918","article-title":"Prognostic role of procalcitonin in ST-elevation myocardial infarction complicated by cardiogenic shock.","volume":"29","author":"Sharma","year":"2021","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R39-20260626","doi-asserted-by":"crossref","first-page":"51","DOI":"10.29001\/2073-8552-2023-38-2-51-56","article-title":"The role of erythropoietin in the regulation of cardiac tolerance to impact of ischemia and reperfusion.","volume":"38","author":"Sufianova","year":"2023","journal-title":"Siberian J Clin Exp Med"},{"key":"R40-20260626","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF01713044","article-title":"Procalcitonin in patients with and without immunosuppression and sepsis.","volume":"24","author":"Al-Nawas","year":"1996","journal-title":"Infection"},{"key":"R41-20260626","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/cc300","article-title":"Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis.","volume":"3","author":"Steinwald","year":"1999","journal-title":"Crit Care"},{"key":"R42-20260626","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00003246-199806000-00015","article-title":"Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.","volume":"26","author":"Nylen","year":"1998","journal-title":"Crit Care Med"},{"key":"R43-20260626","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/109629601317202678","article-title":"Late immunoneutralization of procalcitonin arrest the progression of lethal porcine sepsis.","volume":"2","author":"Martinez","year":"2001","journal-title":"Surg Infect (Larchmt)"},{"key":"R44-20260626","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/CCM.0000000000004731","article-title":"Procalcitonin exerts a mediator role in septic shock through the calcitonin gene-related peptide receptor.","volume":"49","author":"Baranowsky","year":"2021","journal-title":"Crit Care Med"},{"key":"R45-20260626","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2217\/bmm-2017-0160","article-title":"Procalcitonin in heart failure: hic et nunc.","volume":"11","author":"Cvetinovic","year":"2017","journal-title":"Biomark Med"},{"key":"R46-20260626","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-026-12704-0","article-title":"Impact of cardiovascular and metabolic comorbidities on severity and outcomes of hospital-acquired sepsis in intensive care patients: a case-control study.","volume":"26","author":"Roy","year":"2026","journal-title":"BMC Infect Dis"},{"key":"R47-20260626","doi-asserted-by":"crossref","first-page":"e0253894","DOI":"10.1371\/journal.pone.0253894","article-title":"Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: a living systematic review and meta-analysis.","volume":"16","author":"Melo","year":"2021","journal-title":"PLoS One"},{"key":"R48-20260626","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-5273(99)00118-7","article-title":"Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation.","volume":"72","author":"Brunkhorst","year":"1999","journal-title":"Int J Cardiol"},{"key":"R49-20260626","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2020.08.069","article-title":"Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock \u2013 insights from the CardShock study.","volume":"322","author":"Kataja","year":"2021","journal-title":"Int J Cardiol"},{"key":"R50-20260626","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0300-9572(03)00164-3","article-title":"Procalcitonin serum levels after out-of-hospital cardiac arrest.","volume":"59","author":"Fries","year":"2003","journal-title":"Resuscitation"},{"key":"R51-20260626","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2431-8-18","article-title":"Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome.","volume":"8","author":"Los Arcos","year":"2008","journal-title":"BMC Pediatr"},{"key":"R52-20260626","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3906\/sag-1503-64","article-title":"Neurological outcome after cardiac arrest: a prospective study of the predictive ability of prognostic biomarkers neuron-specific enolase, glial fibrillary acidic protein, S-100B, and procalcitonin.","volume":"46","author":"Ok","year":"2016","journal-title":"Turk J Med Sci"},{"key":"R53-20260626","doi-asserted-by":"crossref","first-page":"e14496","DOI":"10.1097\/MD.0000000000014496","article-title":"Combination of S100B and procalcitonin improves prognostic performance compared to either alone in patients with cardiac arrest: a prospective observational study.","volume":"98","author":"Jang","year":"2019","journal-title":"Medicine"},{"key":"R54-20260626","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12985-026-03078-5","article-title":"Diagnostic and prognostic value of serum HBP combined with PCT, CRP, and SAA in early-stage pneumonia.","volume":"23","author":"Cao","year":"2026","journal-title":"Virol J"},{"key":"R55-20260626","first-page":"205","article-title":"Procalcitonin in patients with acute myocardial infarction.","volume":"114","author":"Remskar","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"R56-20260626","doi-asserted-by":"crossref","first-page":"e207030","DOI":"10.1001\/jamanetworkopen.2020.7030","article-title":"Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction.","volume":"3","author":"Reindl","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R57-20260626","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SHK.0000000000000756","article-title":"Infectious complications and immune\/inflammatory response in cardiogenic shock patients: a prospective observational study.","volume":"47","author":"Parenica","year":"2017","journal-title":"Shock"},{"key":"R58-20260626","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.resuscitation.2014.08.007","article-title":"The inflammatory response after out-of-hospital cardiac arrest is not modified by targeted temperature management at 33\u00b0C or 36\u00b0C.","volume":"85","author":"Bro-Jeppesen","year":"2014","journal-title":"Resuscitation"},{"key":"R59-20260626","first-page":"3430","article-title":"Evaluation of the factors affecting mortality after cardiac arrest - do lactate and procalcitonin concentrations have any implications?","volume":"28","author":"Kandilcik","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R60-20260626","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/bja\/aen073","article-title":"Examination of the effect of procalcitonin on human leucocytes and the porcine isolated coronary artery.","volume":"100","author":"Wei","year":"2008","journal-title":"Br J Anaesth"},{"key":"R61-20260626","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1213\/ANE.0000000000001574","article-title":"Procalcitonin impairs endothelial cell function and viability.","volume":"124","author":"Wagner","year":"2017","journal-title":"Anesth Analg"},{"key":"R62-20260626","first-page":"521","article-title":"Effect of procalcitonin on lipopolysaccharide-induced expression of nucleotide-binding oligomerization domain-like receptor protein 3 and caspase-1 in human umbilical vein endothelial cells.","volume":"25","author":"Jiang","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R63-20260626","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/10742484211027405","article-title":"The role of pyroptosis in ischemic and reperfusion injury of the heart.","volume":"26","author":"Popov","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R64-20260626","doi-asserted-by":"crossref","first-page":"120889","DOI":"10.1016\/j.lfs.2022.120889","article-title":"Procalcitonin mediates vascular dysfunction in obesity.","volume":"307","author":"Brabenec","year":"2022","journal-title":"Life Sci"},{"key":"R65-20260626","doi-asserted-by":"crossref","first-page":"1747971","DOI":"10.3389\/fcimb.2026.1747971","article-title":"Biomarker-based diagnosis of ventilator-associated pneumonia using serum and bronchoalveolar lavage fluid levels of presepsin, procalcitonin, and lipopolysaccharide-binding protein.","volume":"16","author":"Ni","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"R66-20260626","first-page":"1","article-title":"Procalcitonin compared to C-reactive protein and leukocyte count. A comparative analysis of baseline markers of bacterial co-infection in patients admitted with a viral respiratory tract infection. A retrospective observational cohort study.","author":"H\u00f8nge","year":"2026","journal-title":"Infect Dis (Lond)"},{"key":"R67-20260626","doi-asserted-by":"crossref","first-page":"1761465","DOI":"10.3389\/fcimb.2026.1761465","article-title":"Systemic inflammation, multi-organ injury, and acute kidney risk in psittacosis pneumonia: a biomarker-driven clinical characterization.","volume":"16","author":"Song","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"R68-20260626","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1186\/s12877-022-03658-4","article-title":"Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study.","volume":"22","author":"Gavazzi","year":"2022","journal-title":"BMC Geriatr"},{"key":"R69-20260626","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cid\/ciaf336","article-title":"Reassessing procalcitonin-guided antibiotic therapy in critically ill patients with sepsis: lessons from the ADAPT-sepsis trial.","volume":"82","author":"Gupta","year":"2026","journal-title":"Clin Infect Dis"},{"key":"R70-20260626","doi-asserted-by":"crossref","first-page":"ciag165","DOI":"10.1093\/cid\/ciag165","article-title":"Impact of procalcitonin testing on antibiotic use in patients hospitalized with community-acquired pneumonia: a multi-hospital cohort study.","author":"Deshpande","year":"2026","journal-title":"Clin Infect Dis"},{"key":"R71-20260626","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/JETS.JETS_61_18","article-title":"Utility of point-of-care ultrasound in differentiating causes of shock in resource-limited setup.","volume":"12","author":"Rahulkumar","year":"2019","journal-title":"J Emerg Trauma Shock"},{"key":"R72-20260626","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/medicina61010103","article-title":"Myocardial infarction-associated shock: a comprehensive analysis of phenotypes, SCAI classification, and outcome assessment.","volume":"61","author":"Dil","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"R73-20260626","doi-asserted-by":"crossref","first-page":"101432","DOI":"10.1016\/j.jacadv.2024.101432","article-title":"Mixed cardiogenic-vasodilatory shock: current insights and future directions.","volume":"4","author":"Jentzer","year":"2024","journal-title":"JACC Adv"},{"key":"R74-20260626","doi-asserted-by":"crossref","first-page":"e011404","DOI":"10.1161\/CIRCHEARTFAILURE.123.011404","article-title":"Mixed shock complicating cardiogenic shock: frequency, predictors, and clinical outcomes.","volume":"17","author":"Baldetti","year":"2024","journal-title":"Circ Heart Fail"},{"key":"R75-20260626","doi-asserted-by":"crossref","first-page":"ytag253","DOI":"10.1093\/ehjcr\/ytag253","article-title":"Percutaneous closure of ventricular septal rupture after myocardial infarction: a case report of competing timelines in multifactorial shock.","volume":"10","author":"Cook","year":"2026","journal-title":"Eur Heart J Case Rep"},{"key":"R76-20260626","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1513\/AnnalsATS.202503-339OC","article-title":"Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine.","volume":"23","author":"Li","year":"2026","journal-title":"Ann Am Thorac Soc"},{"key":"R77-20260626","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MAT.0000000000001933","article-title":"Prognosis of venoarterial extracorporeal membrane oxygenation in mixed, cardiogenic and septic shock.","volume":"69","author":"Kim","year":"2023","journal-title":"ASAIO J"},{"key":"R78-20260626","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/14779072.2023.2295378","article-title":"Trends and cardiovascular outcomes of Takotsubo syndrome with cardiogenic shock vs. mixed cardiogenic and septic shock: a nationwide propensity matched analysis.","volume":"22","author":"Fakhra","year":"2024","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R79-20260626","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1164\/rccm.202201-0054OC","article-title":"Targeting procalcitonin protects vascular barrier integrity.","volume":"206","author":"Brabenec","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R80-20260626","first-page":"100580","article-title":"COVID-19 presenting as takotsubo cardiomyopathy complicated with atrial fibrillation.","volume":"29","author":"Sattar","year":"2020","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:33:52Z","timestamp":1787747632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":80,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001368","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}